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Abstract The grafting of hydroxyapatite/beta-tricalcium
phosphate with b-cyclodextrin was achieved using a two
step reaction with (3-glycidyloxypropyl)trimethoxysilane
as a linker. Firstly, the silane group was brought to react
with the hydroxyl groups at the surface of the hydro-
xyapatite/beta-tricalcium phosphate and secondly, the
epoxy group was brought to react with the b-cyclodextrin.
The amount and distribution of covalently bound b-cyclo-
dextrin were investigated by thermogravimetric analysis,
colorimetric total sugar assay, fluorescence spectroscopy
and confocal laser scanning microscopy. The concentration
of grafted b-cyclodextrin was found to be approximately
3.5 lmol per gram of material corresponding to an almost
complete surface coverage, when assuming a closed hex-
agonal packed monolayer.
Keywords Cyclodextrin  Hydroxyapatite  Grafting 
Drug delivery
Introduction
Infections at the site of implantation in orthopaedic pro-
cedures is a major cause of post operative problems [1] and
may lead to the need of further medical treatments [2]. The
risk of infection can be reduced by treating the patient with
suitable antibiotics, either systemically or locally at the site
of the implant by incorporation of drugs into the device [3].
However, mainly due to low blood circulation in the bone
tissue, systemic administered antibiotics often have a lim-
ited effect [4]. Therefore, it can be necessary to increase
the amount of administered drugs to ensure that the nec-
essary therapeutic concentration is reached in the intended
area [2]. The systemic dose of an administered drug has an
upper limit due to toxicity and other side effects, thus
minimizing the therapeutic window [4]. Local release of
drugs from the implant is a promising method to achieve an
effective dose of a drug at the site where the infection risk
is imminent. However, Duan and Wang [4] state that it can
be very challenging to load a surface of an implant with the
sufficient amount of drug, and at the same time control the
release rate of the drug to have a significant effect. It is
known that cyclodextrins form inclusion complexes with
various antibiotics [5] and other drug molecules [6] and
that cyclodextrins therefore can be used as efficient drug
carriers. This property may be utilised to increase the load
of certain drugs and control the release of the drug from the
implant to the recipient and thereby reduce the risk of a
post operative infection.
Several methods for immobilizing cyclodextrins on sur-
faces, where the cyclodextrin does not contain guest mole-
cules, have been reported [5, 7–16]: Lepretre et al. [5] and
Liu et al. [8] employed a cyclodextrin polymer to physically
coat hydroxyapatite, El Ghoul et al. [9] and Blanchemain
et al. [12] used citric acid as a cross linking agent to physi-
cally fix polymer-cyclodextrin coatings to a surface. Lagrost
et al. [14] covalently modified a silicon surface with a
b-cyclodextrin derivate with seven 1-alkene chains using a
photochemical reaction. Silanisation reactions are also
suitable for the modification of silica gels as demonstrated
by Ponchel et al. [15] and Nielsen et al. [16] who cova-
lently grafted (3-glycidyloxypropyl)trimethoxysilane to the
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surface of silica gel via the silane group and then let the
epoxy group react with a primary or secondary hydroxyl
group of b-cyclodextrin.
Silanisation can also be used to modify hydroxyapatite
as shown by Durrieu et al. [13] who used a silanisation to
covalently bind peptides to the surface.
Direct covalent modification by grafting cyclodextrins
onto hydroxyapatite, beta-tricalcium phosphate or a
biphasic material of the two has, to our knowledge, not
previously been reported in the literature.
We here report the modification and addition of a drug
delivery capability to an implant material which is known
to be osteoconductive and biodegradable [13, 17–20]. We
propose to use (3-glycidyloxypropyl)trimethoxysilane to
graft b-cyclodextrin to a sintered biphasic ceramic material
consisting of 70 mol% hydroxyapatite and 30 mol% beta-
tricalcium phosphate (HA/bTCP), where the silan group
covalently bind to one or more hydroxyl groups on the
surface of HA/bTCP forming ether bonds and then
allowing the epoxy group to react with a primary or sec-
ondary hydroxyl group of b-cyclodextrin.
Materials and methods
The implant material employed was a biphasic material,
consisting of hydroxyapatite (Ca5(PO4)3(OH)) and beta-
tricalcium phosphate (Ca3(PO4)2) in 70:30 molar ratio and
was obtained from FinCeramica, Faenza, Italy as a fine
powder with a mean surface area of 27 m2 per gram. The
porous structures were prepared using CO2 foaming to
produce a ceramic slip with high polymer content, followed
by binder removal and sintering at 1200 C. Prior to use,
the sintered porous material was crushed in a mortar,
washed with ethanol soxhlet extraction for 2 days and
dried in a vacuum oven at 110 C overnight.
b-Cyclodextrin was purchased from Wacker Chemie
GmBH, Germany and dried in a vacuum oven at 60 C
overnight. N,N-dimethylmethanamide (DMF) was obtained
from Fluka, Germany and dried before use with molecular
sieves. (3-glycidyloxypropyl)trimethoxysilane was obtained
from Fluka, Germany. 1-anilinonaphthalen-8-sulfonat (1,8-
ANS) was produced by Fluka, Switzerland. NaOH was pro-
duced by J.T.Baker, Holland.
Grafting of HA/bTCP with b-cyclodextrin
The synthesis was optimized from Ponchel et al. [15] and
illustrated in Fig. 1. In the first step 4.0 g of HA/bTCP
were mixed with 200 ml of DMF in a two-neck-flask with
a flow of nitrogen and a Dean Stark Trap. The solution was
kept at 175 C for 2 h and the distillate, approximately
10 ml, was removed. When the solution had cooled to
95 C, the trap was changed into a condenser. 3.0 ml of (3-
glycidyloxypropyl)trimethoxysilane were added and the
solution was kept at 95 C and left to react for 48 h. In a
separate flask, 2.0 g of b-cyclodextrin were dissolved in
250 ml of DMF and 2.0 g of sodium hydride were added
and left to react for 4 h. Finally, the solution was filtered.
The filtrate was added to the flask containing HA/bTCP,
and left to react for 72 h at 95 C. After this, the mixture
was filtrated and subsequently washed two times with DMF
and two times with demineralised water. Finally, the
powder was washed using soxhlet extraction with water at
reflux temperature for 5 days, and afterwards dried in a
vacuum oven at 70 C.
Quantification of grafted b-cyclodextrin
Thermal gravimetric analysis
Thermal Gravimetric Analysis (TGA) was performed on a
Netzsch STA449C (Erich NETZSCH GmbH & Co., Ger-
many). An empty alumina crucible was weighed and the
sample was placed in the crucible and the weight of the
sample was recorded. The crucible was placed in the oven
and heated in atmospheric air from 50 to 800 C at a
heating rate of 10 C per minute.
Total sugar assay
The spectrophotometric quantification of total sugar, the
phenol assay, was modified from Taylor et al. [21].
Eight solutions of b-cyclodextrin in a concentration
ranging from 0 to 30 mg/L was prepared and 0.6 ml of each
standard were transferred to six test tubes. 2.5 ml of con-
centrated sulphuric acid were added to each test tube and the
tubes were placed in a 50 C water bath for 3 h. After the
tubes have reached room temperature, 75 lL of 90% phenol
solution were added to 3 tubes per standard and none to the
remaining three tubes, which were used as blank controls.
After mixing, the tubes were left to react for 1 h. The sam-
ples where measured twice at 487 nm on a spectrophotom-
eter (Cary 50 Bio UV–Visible spectrophotometer, Varian).
Fig. 1 The synthesis route of grafting HA/bTCP with cyclodextrin
using (3-glycidyloxypropyl)trimethoxysilane as coupling agent
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Samples of HA/bTCP with b-cyclodextrin and samples of
HA/bTCP without b-cyclodextrin were measured by adding
5.0 mg of material and 0.6 mL of demineralised water to a
test tube. The tubes were treated and measured as described
for the standard solutions. Subtracting the two measure-
ments and correlating via the standard curve gave the con-
centration of cyclodextrin in the sample.
Adsorption of 1,8-ANS
To quantify the adsorption of the fluorescence probe to the
surface, the concentration of the probe in the solution was
quantified using a fluorescence spectroscopy: Samples of
15.0 ± 0.1 mg modified and unmodified HA/bTCP were
placed in a 11.5 mL centrifuge tube together with 10 mL
of a solution containing between 5.0 9 10-7 and
1.0 9 10-3 M of 1,8 ANS. The tubes were shaken for 40 h
to ensure equilibrium and afterwards centrifuged at
1620g for 10 min. The standard curve was constructed
from solutions containing between 5.0 9 10-7 and
5.0 9 10-5 M of 1,8 ANS. The samples were measured in
quartz cuvettes on a fluorescence spectrophotometer (Cary
Eclipse Fluorescence Spectrophotometer, Varian) with an
excitation wavelength of 355 nm and an emission wave-
length scanning from 450 to 600 nm where the emission at
522 nm was collected. The gain was set at 770 V. For
some samples dilution with demineralised water was nec-
essary in order to stay within the limits of the standard
curve.
Release of 1,8-ANS
60 mg of HA/bTCP with and without cyclodextrin were
placed in separate 1L blue cap bottles containing 0.5 L of a
5 9 10-5 M 1,8-ANS solution. The bottles were left
shaking for 48 h, where after the solution was filtered and
the powder dried in a vacuum oven at 40 C over night.
25.0 mg of HA/bTCP with and without cyclodextrin
was placed in a small mesh bag and submerged into 75 mL
of demineralised water. Samples were taken at intervals by
removing 3 mL of the solution and replacing it with 3 mL
demineralised water. A standard curve was made with
concentrations ranging from 1 9 10-7 to 5 9 10-5 M. All
samples were measured by fluorescence spectroscopy with
an excitation wavelength of 340 nm and emission was
measured between 420 and 600 nm where the emission at
522 nm was collected.
Confocal laser scanning microscopy
To visualize the presence of cyclodextrin on the particles
and the cyclodextrins ability to form inclusion complexes
with 1,8-ANS, Confocal Laser Scanning Microscope
(CLSM) was employed. 15 mg of sample were added to
10 mL 1.0 9 10-5 M 1,8-ANS and stirred for 24 h. Sus-
pended particles was then withdrawn from the suspension
and placed on a glass slide which was placed in the CLSM
(LSM510 META, Zeiss, Germany). A wavelength of
351 nm was used for excitation and the emission was
collected between 452 and 484 nm. The resolution of the
image was 1024 9 1024 pixels using a 409 objective
which gives a size of the image of 230 9 230 lm.
HA/bTCP with and without (3-glycidyloxypropyl)tri-
methoxysilane was included as references.
Results and discussion
Quantification of grafted b-cyclodextrin
Amount of hydroxyl groups
As the applied syntheses utilize hydroxyl groups on the
surface it is of interest to know the amount of hydroxyl
groups that are available for the reaction. Several different
methods for the quantification of the total amount of
hydroxyl groups in the material have been developed:
Meyer [22] used a titration method where calcium phos-
phates were dissolved using hydrochloric acid and he
concludes that the amount of titratable hydroxyl groups in
the dissolved samples were between 13 and 21% of the
theoretical amount for pure hydroxyapatite. It is known that
stoichiometric hydroxyapatite has a total amount of
2 mmol hydroxyl groups per gram of hydroxyapatite [23],
which means that the material Meyer [22] investigated
contained between 0.26 and 0.42 mmol titratable hydroxyl
groups per gram of dissolved hydroxyapatite. Arends et al.
[24] determined by Fourier transform infrared spectroscopy
(FTIR) and Magic-Angle-Spinning NMR (MAS-NMR) the
total amount of hydroxyl groups in hydroxyapatite to be
10 wt% lower than for stoichiometric hydroxyapatite,
corresponding to 1.8 mmol hydroxyl groups per gram of
material. Cho et al. [25] used two-dimensional solid-state
NMR to determine the amount of hydroxyl groups in bones
and found 20 wt% hydroxyl groups lower than the amount
expected in stoichiometric hydroxyapatite corresponding to
1.6 mmol hydroxyl groups per gram of hydroxyapatite.
From the above mentioned studies it is clear that it is not
possible to generalize on the quantities of hydroxyl groups
on hydroxyapatite and related materials. This may be
caused by differences in materials being used, the origin,
surface area and porosity, as well as differences in analysis
techniques.
Only one paper was found that describes the measure-
ment of hydroxyl groups on the surface of hydroxyapatite.
Tanaka et al. [26] describes a method to measure the
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content of surface active hydroxyl groups by measuring the
amount of methane produced by a reaction with methyl-
magnesium iodide and found a concentration of 2.6
hydroxyl groups per nm2. This value is therefore the best
estimate of the amount of hydroxyl groups on the surface
available to react with the silane group of the linker mol-
ecule. As one b-cyclodextrin covers 1.8 nm2 it is con-
cluded that the amount of hydroxyl groups will not be a
limiting factor in the grafting process.
Qualification of cyclodextrin
To prove that cyclodextrins are covalently bound to the
HA/bTCP surface, two different syntheses were made. The
first synthesis contained HA/bTCP, (3-glycidyloxypro-
pyl)trimethoxysilane and b-cyclodextrin and the second
one contained only HA/bTCP and b-cyclodextrin. The
synthesis route and cleaning procedures are the same as
described for the grafting of HA/bTCP with b-cyclodextrin
in the Material section. When employing the phenol assay
to determine the amount of b-cyclodextrin in samples from
each synthesis, it is clear that no cyclodextrin can be
detected in the sample without (3-glycidyloxypropyl)tri-
methoxysilane, whereas the sample containing (3-glycidyl-
oxypropyl)trimethoxysilane is positive for carbohydrates.
This means that b-cyclodextrin is covalently bound to
the surface of HA/bTCP and the cleaning method
employed is sufficient to remove any b-cyclodextrin not
covalently bound to the surface.
Quantification of grafted b-cyclodextrin
Due to the applied reaction conditions the silan group of (3-
glycidyloxypropyl)trimethoxysilane will primarily react
with hydroxyl groups on HA/bTCP and the epoxy group
will only react with the activated hydroxyl groups of
cyclodextrins which suggests that a monolayer is formed.
Repeated measurements of the surface area with BET
suggested a surface area of 3.6 ± 1.1 m2 per gram of HA/
bTCP but with a poor fit to the isotherm (data not shown)
which is partly reflected in the high standard deviation. If
cyclodextrins are placed in a hexagonal close packed
structure, the maximum theoretical concentration will be
3.0 ± 0.9 lmol b-cyclodextrins per gram of HA/bTCP
corresponding to 0.34 ± 0.1 wt%.
Measurements using thermo gravimetric analysis
showed, as expected that the amount of cyclodextrin rela-
tive to the amount of HA/bTCP was low and the concen-
tration of cyclodextrin was calculated to 2.6 lmol per gram
of HA/bTCP (data not shown). Furthermore, the results
from unmodified HA/bTCP showed a small increase in
weight as function of temperature but with poor repro-
ducibility. This increase was also seen when using an inert
gas as argon and it was not possible to find an explanation
for the weight gain. The poor reproducibility of the HA/
bTCP baseline together with the low content of the organic
part precluded determination of the amount of grafted
cyclodextrin with the desired precision using this tech-
nique. Therefore our focus was shifted to the phenol essay
as the primary method to quantify the cyclodextrins, as this
method quantifies total sugars with a very low detection
limit and a good reproducibility. The phenol essay showed
that concentrations of cyclodextrins in solution as low as
2.5 lmol with a standard deviation in the whole range of
no larger than 0.4 lmol could be determined. The con-
centration of cyclodextrins on HA/bTCP was determined to
be 3.5 ± 0.7 lmol per gram of HA/bTCP.
When considering that the cyclodextrins will only be
able to form a monolayer, it is possible to calculate how
large an area the cyclodextrins will cover, assuming a
hexagonal close packed monolayer. The covered area can
be calculated to 4.2 ± 0.8 m2 per gram of HA/bTCP. This
area corresponds well to the area estimated using BET and
it is therefore reasonable to state that HA/bTCP is nearly
completely covered by a monolayer of cyclodextrins.
As no previous records are available concerning the
covalent grafting of cyclodextrins to the surface of calcium
phosphate, is it difficult to evaluate the efficiency of the
performed modification. However, as mentioned earlier, a
similar synthesis route has been used to modify different
silica gels and as long as the larger surface area of silica
gel, which is between 200 and 600 m2 per gram depending
on the type of silica gel, is taken into account, these results
can be used to assess the efficiency of the performed
synthesis. Therefore, all concentrations of cyclodextrins
are normalised with regard to its surface area to give
cyclodextrins per m2 and are shown in Table 1.
The amount of cyclodextrins bound to the surface of
HA/bTCP is relative high compared with what was found
in literature. Nielsen et al. [16] found for the applied silica
gel, which had 0.076 lmol cyclodextrins per m2, that the
coverage of cyclodextrin is not evenly distributed and that
the highest concentration of cyclodextrins was close to the
surface of the particle. It was proposed that this effect was
due to the pores being blocked by the cyclodextrins and
that this effect therefore is a limiting factor in achieving a
Table 1 Yields of different syntheses normalized with regard to the
surface area
lmol CD per m2 Material
Ponchel et al. [15] 0.14 Silica gel
Stalcup [27] 0.1–0.3 Silica gel
Nielsen et al. [16] 0.076 Silica gel
This work 0.97 HA/bTCP
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higher degree of coverage for silica gels. As the pores of
HA/bTCP are large, it is not expected that clogging of the
pores is an issue and the lack of blockage is the most
plausible explanation to the observed difference in cyclo-
dextrins per m2.
Adsorption of 1,8-ANS
To investigate the adsorption properties of HA/bTCP with
and without b-cyclodextrins towards a guest molecule,
samples were placed in different concentrations of 1,8-
ANS followed by quantification of 1,8-ANS in the water
phase. 1,8-ANS displays a relatively low fluorescence
intensity in water and the lower and upper detection limits
were found to be below 5 9 10-7 and 5 9 10-5 M,
respectively. By adding free b-cyclodextrins to the solu-
tion, it is possible to increase the fluorescence intensity and
thereby obtain a higher sensitivity.
The inclusion complex formation constant, K, can be
calculated from a fit of the data with a suitable adsorption
isotherm. For the adsorption of 1,8-ANS to unmodified
HA/bTCP, the Langmuir isotherm was found to give a
reasonably good fit (see Fig. 2). However, for the adsorp-
tion of 1,8-ANS to cyclodextrin modified HA/bTCP, the
Langmuir isotherm did not give a good fit whereas a fit to
the Bi-Langmuir isotherm resulted in a better fit (see
Fig. 3). It was anticipated that the Bi-Langmuir provided
the best fit to the modified HA/bTCP since this material
contains two types of very distinct adsorption sites, the
cyclodextrin and the calcium phosphate surface.
From the fit of the Langmuir isotherm, the concentration
of binding sites for 1,8-ANS adsorption to unmodified HA/
bTCP is calculated to be 34 lmol per gram of HA/bTCP
with a KHA/bTCP = 15000 ± 1400 M
-1. To better evalu-
ate the result, the number of molecules of 1,8-ANS per nm2
is calculated and results in 5.6 molecules of 1,8-ANS per
nm2. This value is in the high range, but not unlikely as it is
possible that more than one layer is formed.
When fitting the Bi-Langmuir isotherm to the measured
adsorption data from modified HA/bTCP, both the result
from the Langmuir fit and the known concentration of
b-cyclodextrin are used as input for the fitting process. This
results in KCD = 400000 M
-1 and the concentration of
binding sites to 3.6 and 2.6 lmol per gram of HA/bTCP for
cyclodextrins and unmodified surface, respectively. The
change in the concentration of binding sites with regards to
modified HA/bTCP was anticipated because cyclodextrins
occupy most of the surface.
Literature studies have shown that the stability constant
between 1,8-ANS and b-cyclodextrin dissolved in water is
between 100 and 300 M-1 [14, 28–30]. This value is
considerably lower than the above measured binding con-
stant of 400000 M-1, but the difference was expected
as both Lagrost et al. [14] and Beulen et al. [28] deter-
mined stability constants for 1,8-ANS to 390000 and
289000 M-1, respectively, for b-cyclodextrins attached to
a surface in a monolayer. It is proposed that this large
increase in binding constant is a combination of a coop-
erative effect between the cyclodextrin and the surface
Fig. 2 The concentration of free 1,8-ANS plotted versus the
concentration of 1,8-ANS bound to the surface of unmodified HA/
bTCP (dots) together with the fitted Langmuir isotherm (line)
Fig. 3 Top the concentration of free 1,8-ANS versus the concentra-
tion of 1,8-ANS bound to the surface of HA/bTCP with cyclodextrin.
Bottom the concentration of free 1,8-ANS versus the concentration of
1,8-ANS bound to the surface of HA/bTCP with cyclodextrin divided
by the bound 1,8-ANS (dots) plotted together with the fitted Bi-
Langmuir isotherm (line)
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together with a reduced loss of entropy upon formation of
the inclusion complex compared to the complex formed in
solution.
Release of 1,8-ANS
The release of 1,8-ANS shows that HA/bTCP with cyclo-
dextrin is releasing considerably more 1,8-ANS than
unmodified HA/bTCP (see Fig. 4). HA/bTCP with cyclo-
dextrin is, in the current setup, releasing a total of 3.4 lmol
1,8-ANS per gram of HA/bTCP which is approximately
equal to the theoretical maximum of approximately
3.5 lmol per gram of HA/bTCP. Whereas unmodified HA/
bTCP releases 1.6 lmol 1,8-ANS per gram of HA/bTCP.
This result clearly demonstrates that cyclodextrins can
be used to increase the amount of a drug and change the
release rate of a drug that can be released from a porous
material like HA/bTCP. This effect will be highly depen-
dent on the used drug, but a thorough study of the release
functionality and consideration of effectiveness is outside
the scope of this article.
Confocal laser scanning microscope
A useful property of 1,8-ANS and other isomers of ANS, is
their ability to emit fluorescence in hydrophobic environ-
ments such as inside the cavity of a cyclodextrin [30]. It is
therefore possible to use the change in fluorescence
intensity of 1,8-ANS as a marker for the 1,8-ANS cyclo-
dextrin inclusion complex and thus distinguish between
Fig. 4 Accumulated concentration of 1,8-ANS from HA/bTCP with
and without cyclodextrin
Fig. 5 Light transmission
microscopy (left) and CLSM
(right) images of HA/bTCP
particles in a suspension of 1,8-
ANS. a Unmodified HA/bTCP
particle. b HA/bTCP coated
with b-cyclodextrin. The scale
bar is 40 lm for all pictures
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surface adsorption and inclusion complex formation with
cyclodextrins.
Samples containing 1,8-ANS with and without cyclo-
dextrins were studied both using normal light transmission
microscopy revealing the shape of the actual particle and
with the CLSM revealing focal distribution of fluorescence.
Figure 5a shows the light transmission microscopy image
(left) and the corresponding CLSM image (right) where
fluorescence should appear as bright areas. In the fluores-
cence image, it is not possible to see any bright areas which
document that 1,8-ANS does not emit significant fluores-
cence when adsorbed to the surface of unmodified HA/
bTCP or in solution. The CLSM images for the control,
HA/bTCP coated with (3-glycidyloxypropyl)trimethoxysi-
lane in a solution of 1,8-ANS (data not shown) yielded
comparable results showing that (3-glycidyloxypropyl)tri-
methoxysilane does not affect the fluorescence of 1,8-ANS.
The samples coated with b-cyclodextrin are seen in
Fig. 5b, where the bright areas indicate the fluorescence
from 1,8-ANS (right).
When comparing the three CLSM images, it is clear that
the presence of cyclodextrins on the surface of the particle
together with 1,8-ANS gives rise to a significant increase in
the fluorescence signal and it is therefore evident that
the surface of the samples contains cyclodextrins and that
1,8-ANS indeed is forming an inclusion complex with
b-cyclodextrin. The fluorescence intensity varies on the
surface due to structural variations of the material but also
a heterogeneous distribution of cyclodextrins will contrib-
ute to this variation.
Due to the rather high density of the particle it was not
possible to measure the distribution of cyclodextrins inside
the particles as the excitation light cannot fully penetrate
the particle and thus the 1,8-ANS cyclodextrin inclusion
complexes situated deep inside the pores of the particles
will not emit fluorescence. Some particles were therefore
grinded to see if a difference in fluorescence was visible,
thereby indicating a variation in distribution of cyclodex-
trin and 1,8 ANS. However, no differences were apparent
which is either because no fragments from the interior of
the particle was found and examined or, which is more
likely, that cyclodextrin and 1,8-ANS is present throughout
the particle.
To test if the cyclodextrins are present inside the particle
and still capable of forming complexes with 1,8-ANS,
smaller particles were analysed (see Fig. 6). As seen from
the light transmission microscopy image the size of this
particle was approximately 15 lm long, 12 lm wide and
16 lm high and the fluorescence was emitted throughout
the interior of the particle.
All of the CLSM images revealed a uniform distribution
of fluorescence with only small local areas with somewhat
lower emission revealing that inclusion complexes between
b-cyclodextrin and 1,8-ANS is distributed throughout the
interior of the particle, even though the intensity is varying.
It is therefore evident that cyclodextrins have been cova-
lently bound both at the surface but also inside the porous
particles, at least to a depth of 8 lm.
For silica gel with a mean pore size of 10 nm, we have
previously reported that inclusion complexes between
b-cyclodextrin and 1,8-ANS can mainly be detected near
the surface due to blocking of the pores [16]. However, as
HA/bTCP and silica gel have very different pore structures,
it is difficult to draw any conclusion, but it is likely that the
bigger interconnected pores of HA/bTCP will decrease the
likelihood of pore blocking drastically and thereby a near
total coverage of the entire surface is possible.
Conclusion
The amount of b-cyclodextrins grafted to HA/bCP was
quantified to 3.5 lmol per gram of HA/bTCP corre-
sponding to an almost complete surface coverage. The
adsorption of a model molecule with affinity towards
b-cyclodextrin (1,8-ANS) could be fitted using the Bi-
Langmuir binding isotherm. Thus, the modified material
contains two distinct binding sites for 1,8-ANS, the
unmodified surface and the cyclodextrins with binding
constants of 15000 and 400000 M-1 respectively.
Fig. 6 Top left is a light transmission microscopy image of a particle
with a size of 12 9 15 9 16 lm. The following images are CLSM
images taken at different depths of the particle (2, 4, 6, 8, 10, 12, 14
and 16 lm)
J Incl Phenom Macrocycl Chem
123
The results from CLSM demonstrate the presence of
cyclodextrins both at the surface but also at least 8 lm
inside the particles. However, it is not possible to see if the
cyclodextrins are situated in the core of larger particles
with a particle size of 80 lm because the excitation light
has a limited penetration into HA/bTCP, but grinded
samples indicates that cyclodextrins are present throughout
the particles. The penetration depth of the excitation light
was found to be at least 16 lm but well below 80 lm.
The fluorescence experiments furthermore showed that
the surface bound cyclodextrins are available to form
inclusion complexes with molecules and, as demonstrated
for 1,8-ANS, with dramatically increased binding constants
compared to complex formation in solution. The molecules
that interact with the cyclodextrins can be released again,
and it is therefore concluded that low concentrations of
cyclodextrins grafted to a surface will increase the amount
of drug that can be released to the recipient.
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